Aleksandra Zuraw, toxicologic pathologist and owner of the digital pathology blog Digital Pathology Consulting (http://www.digitalpathologyconsulting.com), released an article documenting trends taking place in digital pathology. Included in these recent trends is Augmentiqs, a technology that definitely represents a paradigm shift in how digital pathology functionality can be achieved.
Augmentiqs technology stands apart from traditional Whole Slide Imaging which separates the pathologist from the microscope. Instead, Augmentiqs has taken a microscope-centric approach to digital pathology, providing pathologists a cost-efficient and low-data method for realizing clinical and workflow enhancements. By connecting the analog microscope to the computer, Augmentiqs maintains the advantages of the microscope for workflow and primary diagnosis, while improving efficiency with the introduction of pathology software applications directly from the microscope. By functioning as a platform for real-time software deployment, Augmentiqs allows pathologists immediate access to imaging, analytical software, telepathology, LIMS integration and other digital pathology applications.
“The digital pathology providers even started providing solutions (hardware and software) for those who want to keep working with the microscope. The company Augmentiqs provides an alternative, flat camera unit (aka augmented reality module) which can be attached to your own microscope between the objectives and the eyepiece to enable working with digital and analog pathology at the same time. The image from the microscope is transmitted live to the computer where not only can it be shared live with collaborators, but also digital image analysis algorithms and deep learning models can be applied. This gives it a great advantage over a c-mounted microscope camera for capturing static images, where the live sharing experience is either not possible or suboptimal. No matter how far the digitalization of pathology progresses, microscopes and light microscopy are the basis of current pathologic evaluation and are here to stay. Maybe in the future, they will be available just as back-up equipment, but in many regions of the world, from the rural mid-west of the United States to Malawi in Africa as the only tool of pathological evaluation. The fact that microscopes will remain in the pathology world along with the augmented reality units contributes to greater adoption of digital pathology even among the more skeptical pathologists, as well as empowers the institutions that cannot afford to go fully digital in their laboratories.”